Fluid Overload Clinical Trial
Official title:
Fluid Mobilization in Hospitalized Patients With Acute Kidney Injury
Verified date | August 2020 |
Source | University of California, San Diego |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Hospitalized patients often suffer from an acute shutdown of kidney function secondary to infections, use of antibiotics, or use of intravenous contrast agents. This results in the accumulation of toxic substances and retention of fluid in the body. Dialysis techniques are often needed to manage these patients to remove the retained toxic substances and extra fluid and allow the kidney time to recover. The amount and duration of fluid accumulation have been associated with a higher risk of death and longer hospital stays. Correction of fluid overload with dialysis has been shown to be beneficial in improving the outcomes from these patients. Most patients are quite sick and often have low levels of a blood protein called albumin that makes them more prone to developing low blood pressure during dialysis and limits the ability of dialysis to remove solutes and fluid adequately. Often dialysis sessions are complicated by the development of low blood pressures and symptoms such as nausea, vomiting, and headaches that further compromises dialysis efficacy. In this study, the hypothesis that addition of intravenous albumin during the dialysis session will improve the ability to remove fluid and reduce the incidence of low blood pressure during dialysis thereby improving patient tolerance and the efficacy of the procedure will be tested. Patients with acute kidney failure or end-stage Renal Disease who need dialysis for fluid removal will be allocated to receive albumin or saline as intravenous fluids during individual dialysis sessions and information on how much fluid can be removed and how many complications occur in each session will be recorded. Dialysis sessions with albumin will be compared with those with saline alone to determine the benefit of adding albumin to the treatment. Information obtained from this study will allow physicians to manage patients requiring dialysis for acute kidney failure more effectively and help improve outcomes.
Status | Completed |
Enrollment | 65 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 15, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - age > 18 years old - need for intermittent hemodialysis during hospitalization - hypoalbuminemia (albumin<3g/dl) Exclusion Criteria: - allergy to the components of albumin |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of California, San Diego | Grifols Biologicals, LLC |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | fluid removal | achieved fluid removal expressed as ml/kg/hour | during procedure | |
Secondary | hypotension | cardiovascular complications, including hypotensive episodes | during procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Completed |
NCT05070819 -
Atrial Natriuretic Peptide in Assessing Fluid Status
|
N/A | |
Withdrawn |
NCT04870073 -
Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery
|
Phase 3 | |
Recruiting |
NCT02989051 -
Fluid Restriction Keeps Children Dry
|
Phase 2/Phase 3 | |
Completed |
NCT00517127 -
Crystalloids Versus Colloids During Surgery
|
Phase 4 | |
Completed |
NCT00852514 -
The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance Analysis
|
Phase 4 | |
Not yet recruiting |
NCT05983549 -
Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial
|
N/A | |
Completed |
NCT03929471 -
Target Weight Correction and Vascular Stiffness in Hemodialysis Patients
|
N/A | |
Recruiting |
NCT06071026 -
Hemodynamic Effects of Variations in Net Ultrafiltration Rate During Continuous Renal Replacement Therapy.
|
N/A | |
Completed |
NCT02903316 -
Predicting Fluid Responsiveness in on Pump Coronary Artery Bypass Graft Using Extra Systoles
|
N/A | |
Terminated |
NCT02458157 -
Forced Fluid Removal in High Risk Acute Kidney Injury
|
Phase 4 | |
Completed |
NCT02325856 -
Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients
|
N/A | |
Completed |
NCT01628731 -
Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease
|
Phase 3 | |
Not yet recruiting |
NCT05647200 -
Optimization of Prime Fluid Strategy to Preserve Microcirculatory Perfusion During Cardiac Surgery With Cardiopulmonary Bypass, Part II
|
N/A | |
Completed |
NCT03768752 -
Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients
|
||
Terminated |
NCT03553394 -
Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients
|
N/A | |
Completed |
NCT06097923 -
Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU)
|
N/A | |
Recruiting |
NCT04215692 -
Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients
|
N/A | |
Not yet recruiting |
NCT03322410 -
Hydratation Status at Initiation of Peritoneal Dialysis: Study of the Role of Peritoneal Permeability
|
N/A |